These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1967844)

  • 21. New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes.
    Griebel G; Perrault G; Letang V; Granger P; Avenet P; Schoemaker H; Sanger DJ
    Psychopharmacology (Berl); 1999 Sep; 146(2):205-13. PubMed ID: 10525757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wake-promoting and sleep-suppressing actions of hypocretin (orexin): basal forebrain sites of action.
    España RA; Baldo BA; Kelley AE; Berridge CW
    Neuroscience; 2001; 106(4):699-715. PubMed ID: 11682157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats.
    Thakkar MM; Ramesh V; Strecker RE; McCarley RW
    Arch Ital Biol; 2001 Apr; 139(3):313-28. PubMed ID: 11330208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem.
    Kralic JE; O'Buckley TK; Khisti RT; Hodge CW; Homanics GE; Morrow AL
    Neuropharmacology; 2002 Sep; 43(4):685-94. PubMed ID: 12367614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep and Sedative States Induced by Targeting the Histamine and Noradrenergic Systems.
    Yu X; Franks NP; Wisden W
    Front Neural Circuits; 2018; 12():4. PubMed ID: 29434539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the sleep-wake cycle: sleep, insomnia, and the orexin system.
    Krystal AD; Benca RM; Kilduff TS
    J Clin Psychiatry; 2013; 74 Suppl 1():3-20. PubMed ID: 24107804
    [No Abstract]   [Full Text] [Related]  

  • 28. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats.
    Szymusiak R; Alam N; Steininger TL; McGinty D
    Brain Res; 1998 Aug; 803(1-2):178-88. PubMed ID: 9729371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep and hypnotic drugs.
    Johns MW
    Drugs; 1975; 9(6):448-78. PubMed ID: 238826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sleep circuitry and the hypnotic mechanism of GABAA drugs.
    Lu J; Greco MA
    J Clin Sleep Med; 2006 Apr; 2(2):S19-26. PubMed ID: 17557503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The differential effects of short- and long-acting benzodiazepines upon nocturnal sleep and daytime performance.
    Roth T; Hartse KM; Zorick FJ; Kaffeman ME
    Arzneimittelforschung; 1980; 30(5a):891-4. PubMed ID: 6106491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypnotic efficacy and clinical safety of midazolam in shift-workers.
    Scollo-Lavizzari G
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):73S-78S. PubMed ID: 6138084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and sedative effects of benzodiazepine use.
    Buffett-Jerrott SE; Stewart SH
    Curr Pharm Des; 2002; 8(1):45-58. PubMed ID: 11812249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of parenterally administered triazolam on sleep in rats with lesions of the preoptic area.
    Mendelson WB
    Pharmacol Biochem Behav; 1998 Sep; 61(1):81-6. PubMed ID: 9715809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the hypnotic effects of triazolam microinjections into the medial preoptic area.
    Mendelson WB; Martin JV
    Life Sci; 1992; 50(15):1117-28. PubMed ID: 1556906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The GABAA-BZR complex as target for the development of anxiolytic drugs.
    Trincavelli ML; Da Pozzo E; Daniele S; Martini C
    Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of alpha-2 receptors in the medial preoptic area in the regulation of sleep-wakefulness and body temperature.
    Ramesh V; Kumar VM
    Neuroscience; 1998 Aug; 85(3):807-17. PubMed ID: 9639274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of 1,5 benzodiazepine beta lactam on sleep].
    Ayala-Guerrero F; Vargas-Reyna L; Taboada J; Martinez R; Cortes E
    Gac Med Mex; 1993; 129(2):119-23. PubMed ID: 7926392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats.
    Lobarinas E; Falk JL
    Psychopharmacology (Berl); 2000 Apr; 149(2):176-80. PubMed ID: 10805613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diazepam-induced changes in sleep: role of the alpha 1 GABA(A) receptor subtype.
    Tobler I; Kopp C; Deboer T; Rudolph U
    Proc Natl Acad Sci U S A; 2001 May; 98(11):6464-9. PubMed ID: 11353839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.